| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Like Growth Factor I | 14 | 2022 | 110 | 2.550 |
Why?
|
| Receptor, IGF Type 1 | 9 | 2020 | 42 | 1.470 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2010 | 219 | 1.420 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 8 | 2022 | 14 | 1.230 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2018 | 331 | 0.920 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2017 | 624 | 0.870 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 332 | 0.860 |
Why?
|
| Signal Transduction | 12 | 2020 | 2689 | 0.820 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 4 | 2006 | 46 | 0.790 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 4 | 2010 | 24 | 0.780 |
Why?
|
| Head and Neck Neoplasms | 5 | 2017 | 561 | 0.780 |
Why?
|
| Neoplasms | 5 | 2018 | 1664 | 0.730 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2018 | 195 | 0.680 |
Why?
|
| Receptor, Insulin | 9 | 1996 | 71 | 0.530 |
Why?
|
| Pigment Epithelium of Eye | 2 | 2004 | 28 | 0.480 |
Why?
|
| Receptors, Cell Surface | 8 | 1994 | 248 | 0.480 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 1070 | 0.450 |
Why?
|
| Glomerular Mesangium | 6 | 2006 | 53 | 0.430 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2011 | 100 | 0.390 |
Why?
|
| Somatomedins | 2 | 2010 | 16 | 0.390 |
Why?
|
| Phosphoproteins | 2 | 2010 | 202 | 0.390 |
Why?
|
| Amino Acid Sequence | 10 | 2010 | 1082 | 0.390 |
Why?
|
| Molecular Sequence Data | 10 | 2010 | 1446 | 0.380 |
Why?
|
| Retina | 5 | 1995 | 252 | 0.350 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2006 | 16 | 0.340 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 214 | 0.330 |
Why?
|
| Recombinant Proteins | 4 | 2010 | 742 | 0.320 |
Why?
|
| Cell Movement | 2 | 2012 | 630 | 0.320 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 236 | 0.320 |
Why?
|
| Autocrine Communication | 2 | 2006 | 37 | 0.300 |
Why?
|
| Immunoblotting | 8 | 2006 | 254 | 0.300 |
Why?
|
| Pancreas | 6 | 1991 | 225 | 0.290 |
Why?
|
| Animals | 32 | 2020 | 20880 | 0.290 |
Why?
|
| Peptides, Cyclic | 1 | 2006 | 35 | 0.270 |
Why?
|
| Ligands | 5 | 2010 | 317 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2006 | 250 | 0.260 |
Why?
|
| Nanotubes | 2 | 2018 | 22 | 0.250 |
Why?
|
| Cell Nucleus | 4 | 2012 | 305 | 0.250 |
Why?
|
| Cholecystokinin | 7 | 1987 | 29 | 0.250 |
Why?
|
| Biotin | 1 | 2004 | 28 | 0.250 |
Why?
|
| Binding, Competitive | 9 | 2004 | 165 | 0.240 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1998 | 107 | 0.230 |
Why?
|
| Transcription Factors | 2 | 2004 | 753 | 0.220 |
Why?
|
| Humans | 27 | 2022 | 68549 | 0.220 |
Why?
|
| Phosphorylation | 10 | 2006 | 1200 | 0.220 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2022 | 4 | 0.210 |
Why?
|
| Transfection | 4 | 2019 | 782 | 0.210 |
Why?
|
| Molecular Weight | 11 | 1995 | 358 | 0.200 |
Why?
|
| Cobalt | 3 | 2006 | 37 | 0.190 |
Why?
|
| Cell Membrane | 10 | 1995 | 524 | 0.190 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 1992 | 195 | 0.190 |
Why?
|
| Photoaffinity Labels | 1 | 2000 | 7 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2006 | 223 | 0.190 |
Why?
|
| Azides | 1 | 2000 | 56 | 0.190 |
Why?
|
| Cell Line | 7 | 2010 | 1752 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2006 | 71 | 0.180 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 3 | 1995 | 3 | 0.180 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 38 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 369 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 3 | 2005 | 322 | 0.180 |
Why?
|
| Receptors, Cholecystokinin | 5 | 1988 | 8 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2019 | 17 | 0.170 |
Why?
|
| Peroxiredoxins | 1 | 2019 | 34 | 0.170 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 80 | 0.170 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 71 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2004 | 272 | 0.160 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 1851 | 0.160 |
Why?
|
| Cells, Cultured | 10 | 2010 | 2673 | 0.160 |
Why?
|
| Phenotype | 2 | 2019 | 946 | 0.160 |
Why?
|
| Glucose | 2 | 2006 | 307 | 0.150 |
Why?
|
| Insulin | 4 | 1996 | 617 | 0.150 |
Why?
|
| Gene Expression Regulation | 4 | 2006 | 1293 | 0.150 |
Why?
|
| Genes, p53 | 1 | 2017 | 41 | 0.150 |
Why?
|
| Fibroblasts | 3 | 2019 | 902 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2017 | 61 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2010 | 384 | 0.140 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 213 | 0.140 |
Why?
|
| Protein Binding | 3 | 2022 | 1027 | 0.130 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1995 | 19 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 231 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2004 | 682 | 0.130 |
Why?
|
| Retinoblastoma | 1 | 1995 | 26 | 0.130 |
Why?
|
| Ciliary Body | 1 | 1995 | 52 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2006 | 1663 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2006 | 312 | 0.120 |
Why?
|
| Receptors, Chemokine | 1 | 1994 | 26 | 0.120 |
Why?
|
| Rats | 14 | 1998 | 5300 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 331 | 0.120 |
Why?
|
| Hypoxia | 2 | 2006 | 169 | 0.120 |
Why?
|
| Mouth Neoplasms | 2 | 2009 | 206 | 0.120 |
Why?
|
| Succinimides | 4 | 2004 | 11 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1174 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2019 | 718 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 852 | 0.110 |
Why?
|
| Binding Sites | 3 | 2004 | 631 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 12 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1994 | 167 | 0.110 |
Why?
|
| Synaptosomes | 1 | 1992 | 57 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2013 | 113 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 86 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2004 | 954 | 0.100 |
Why?
|
| Dinoprostone | 2 | 2010 | 110 | 0.100 |
Why?
|
| Trastuzumab | 1 | 2011 | 17 | 0.100 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2011 | 37 | 0.100 |
Why?
|
| Macrophages, Alveolar | 1 | 1991 | 34 | 0.100 |
Why?
|
| Anura | 1 | 1991 | 9 | 0.100 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 1991 | 1 | 0.100 |
Why?
|
| Drug Resistance, Multiple | 1 | 2011 | 56 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 3 | 2009 | 261 | 0.100 |
Why?
|
| Mice | 7 | 2019 | 8474 | 0.100 |
Why?
|
| Tyrosine | 1 | 1991 | 196 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 151 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1085 | 0.090 |
Why?
|
| Models, Molecular | 2 | 2004 | 546 | 0.090 |
Why?
|
| Pseudopodia | 1 | 2010 | 16 | 0.090 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 53 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 163 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2011 | 239 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 1991 | 271 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 120 | 0.090 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 20 | 0.090 |
Why?
|
| Oligosaccharides | 2 | 1991 | 26 | 0.090 |
Why?
|
| Tumor Escape | 1 | 2010 | 37 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 139 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 1996 | 71 | 0.090 |
Why?
|
| Pyrroles | 2 | 2010 | 83 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 415 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 511 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 191 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2010 | 597 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 756 | 0.080 |
Why?
|
| Acetylglucosaminidase | 2 | 1985 | 8 | 0.080 |
Why?
|
| Proteomics | 1 | 2010 | 246 | 0.080 |
Why?
|
| Affinity Labels | 4 | 1995 | 66 | 0.080 |
Why?
|
| Receptors, Somatomedin | 3 | 1991 | 7 | 0.080 |
Why?
|
| Kinetics | 6 | 1997 | 1047 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 1996 | 791 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 507 | 0.070 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 57 | 0.070 |
Why?
|
| Peptide Library | 1 | 2006 | 16 | 0.070 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2006 | 13 | 0.070 |
Why?
|
| Hexosaminidases | 2 | 1991 | 7 | 0.070 |
Why?
|
| Androstadienes | 1 | 2006 | 41 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1549 | 0.070 |
Why?
|
| Skatole | 1 | 2005 | 1 | 0.070 |
Why?
|
| Culture Media, Conditioned | 1 | 2006 | 78 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1990 | 529 | 0.070 |
Why?
|
| Mesangial Cells | 1 | 2006 | 37 | 0.070 |
Why?
|
| Chromatography, Affinity | 3 | 1992 | 73 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 77 | 0.070 |
Why?
|
| Tryptophan | 1 | 2005 | 65 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2005 | 89 | 0.070 |
Why?
|
| Sirolimus | 1 | 2006 | 118 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2000 | 483 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1998 | 317 | 0.060 |
Why?
|
| Asparagine | 1 | 1985 | 15 | 0.060 |
Why?
|
| Phagocytes | 1 | 1985 | 15 | 0.060 |
Why?
|
| DNA Replication | 1 | 2006 | 167 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 226 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2006 | 178 | 0.060 |
Why?
|
| Biotinylation | 1 | 2004 | 27 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 1985 | 72 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 100 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 1 | 2004 | 50 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2004 | 72 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2004 | 165 | 0.060 |
Why?
|
| CHO Cells | 1 | 2004 | 161 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2004 | 49 | 0.060 |
Why?
|
| Cricetinae | 1 | 2004 | 262 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 765 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 614 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 499 | 0.060 |
Why?
|
| Choroidal Neovascularization | 1 | 2004 | 35 | 0.060 |
Why?
|
| Islets of Langerhans | 3 | 1979 | 87 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1174 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2010 | 2791 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 1533 | 0.050 |
Why?
|
| Liver | 4 | 1994 | 1118 | 0.050 |
Why?
|
| Peptides | 3 | 2018 | 455 | 0.050 |
Why?
|
| Placenta | 2 | 1995 | 101 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 1998 | 140 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 82 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 306 | 0.050 |
Why?
|
| Diabetic Nephropathies | 2 | 2006 | 161 | 0.050 |
Why?
|
| Base Sequence | 2 | 2010 | 1015 | 0.050 |
Why?
|
| Bufo marinus | 2 | 1994 | 23 | 0.050 |
Why?
|
| Models, Biological | 1 | 2006 | 981 | 0.050 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 3 | 1987 | 19 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 1992 | 122 | 0.050 |
Why?
|
| Oleic Acid | 2 | 1998 | 40 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 1172 | 0.050 |
Why?
|
| Cell Division | 2 | 1998 | 541 | 0.050 |
Why?
|
| Mutation | 1 | 2005 | 1213 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1745 | 0.040 |
Why?
|
| Brain | 1 | 1990 | 2176 | 0.040 |
Why?
|
| Glucagon | 3 | 1991 | 22 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2000 | 284 | 0.040 |
Why?
|
| Anthracenes | 1 | 2019 | 26 | 0.040 |
Why?
|
| Glycoside Hydrolases | 2 | 1991 | 25 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 61 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 1026 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 168 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2018 | 46 | 0.040 |
Why?
|
| Pharmaceutic Aids | 1 | 1998 | 7 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 326 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2010 | 241 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2018 | 71 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 532 | 0.040 |
Why?
|
| Actins | 1 | 2019 | 249 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 170 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 397 | 0.040 |
Why?
|
| Tubulin | 1 | 1997 | 60 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 1998 | 107 | 0.040 |
Why?
|
| Molecular Motor Proteins | 1 | 2017 | 14 | 0.040 |
Why?
|
| Rabbits | 2 | 1995 | 509 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 49 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 567 | 0.040 |
Why?
|
| Angiotensin II | 1 | 1998 | 220 | 0.040 |
Why?
|
| Bradykinin | 1 | 1997 | 157 | 0.040 |
Why?
|
| Oleic Acids | 1 | 1996 | 40 | 0.040 |
Why?
|
| DNA Probes | 1 | 1996 | 57 | 0.040 |
Why?
|
| Mitosis | 1 | 1996 | 76 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 230 | 0.030 |
Why?
|
| Neuroglia | 1 | 1996 | 136 | 0.030 |
Why?
|
| Protein Precursors | 2 | 1991 | 105 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.030 |
Why?
|
| Cattle | 2 | 1991 | 475 | 0.030 |
Why?
|
| Sincalide | 2 | 1988 | 12 | 0.030 |
Why?
|
| Epitopes | 2 | 1995 | 146 | 0.030 |
Why?
|
| Thymidine | 2 | 2010 | 32 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1996 | 270 | 0.030 |
Why?
|
| Trypsin | 1 | 1995 | 64 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 532 | 0.030 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1995 | 17 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 1995 | 60 | 0.030 |
Why?
|
| Receptors, CXCR | 1 | 1994 | 2 | 0.030 |
Why?
|
| Dogfish | 1 | 1994 | 7 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1994 | 21 | 0.030 |
Why?
|
| Female | 6 | 2019 | 38021 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 562 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1994 | 282 | 0.030 |
Why?
|
| Antibodies | 2 | 1994 | 241 | 0.030 |
Why?
|
| Dibutyryl Cyclic GMP | 2 | 1983 | 4 | 0.030 |
Why?
|
| Chick Embryo | 1 | 1994 | 379 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1994 | 231 | 0.030 |
Why?
|
| Cyclic GMP | 2 | 1983 | 99 | 0.030 |
Why?
|
| Breast Neoplasms, Male | 1 | 2013 | 12 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2012 | 12 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 1990 | 164 | 0.030 |
Why?
|
| Caveolin 1 | 1 | 2013 | 59 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2013 | 60 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2012 | 155 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 1991 | 1 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1991 | 18 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 137 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 1991 | 25 | 0.030 |
Why?
|
| Calcitonin | 1 | 1991 | 21 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1991 | 88 | 0.030 |
Why?
|
| Secretin | 1 | 1991 | 18 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 1991 | 46 | 0.030 |
Why?
|
| Carbohydrates | 1 | 1991 | 57 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 235 | 0.020 |
Why?
|
| Reference Values | 1 | 1992 | 579 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1991 | 223 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 1991 | 80 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1992 | 314 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 189 | 0.020 |
Why?
|
| Osteoclasts | 1 | 1991 | 132 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 434 | 0.020 |
Why?
|
| Male | 8 | 2013 | 37283 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 99 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 85 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1641 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 302 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 46 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 1992 | 617 | 0.020 |
Why?
|
| Indomethacin | 1 | 2010 | 107 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 82 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 137 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 204 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2010 | 133 | 0.020 |
Why?
|
| Perforin | 1 | 2009 | 12 | 0.020 |
Why?
|
| Granzymes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 362 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 230 | 0.020 |
Why?
|
| Indoles | 1 | 2010 | 146 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 77 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 346 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2010 | 368 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 643 | 0.020 |
Why?
|
| Membranes | 1 | 1987 | 26 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 447 | 0.020 |
Why?
|
| Cell Count | 2 | 1998 | 248 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 371 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2006 | 18 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2006 | 77 | 0.020 |
Why?
|
| Receptors, Formyl Peptide | 1 | 1985 | 4 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1985 | 9 | 0.020 |
Why?
|
| Papain | 1 | 1985 | 6 | 0.020 |
Why?
|
| Tunicamycin | 1 | 1985 | 10 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1985 | 119 | 0.020 |
Why?
|
| Flavobacterium | 1 | 1984 | 6 | 0.020 |
Why?
|
| Pregnancy | 1 | 1990 | 2334 | 0.020 |
Why?
|
| Neuraminidase | 1 | 1984 | 36 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1985 | 152 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1985 | 228 | 0.010 |
Why?
|
| Monocytes | 1 | 1985 | 210 | 0.010 |
Why?
|
| Neutrophils | 1 | 1985 | 204 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1987 | 332 | 0.010 |
Why?
|
| Autoradiography | 1 | 1983 | 94 | 0.010 |
Why?
|
| Oral Surgical Procedures | 1 | 2003 | 15 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 351 | 0.010 |
Why?
|
| Microsurgery | 1 | 2003 | 46 | 0.010 |
Why?
|
| Life Style | 1 | 2003 | 338 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 951 | 0.010 |
Why?
|
| Canavanine | 1 | 1979 | 1 | 0.010 |
Why?
|
| Proinsulin | 1 | 1979 | 3 | 0.010 |
Why?
|
| Diet | 1 | 2003 | 514 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 848 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1979 | 181 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1998 | 48 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 1998 | 31 | 0.010 |
Why?
|
| Solubility | 2 | 1991 | 134 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1997 | 41 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 1998 | 80 | 0.010 |
Why?
|
| Cytosol | 1 | 1997 | 123 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 134 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1998 | 260 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1998 | 155 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 14842 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1997 | 337 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1996 | 48 | 0.010 |
Why?
|
| Aorta | 1 | 1998 | 316 | 0.010 |
Why?
|
| Biological Transport | 1 | 1996 | 210 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 1996 | 107 | 0.010 |
Why?
|
| Stem Cells | 1 | 1996 | 248 | 0.010 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1996 | 183 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 21119 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 21379 | 0.010 |
Why?
|
| Astrocytes | 1 | 1996 | 270 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1994 | 144 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1996 | 626 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 282 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 659 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 2083 | 0.010 |
Why?
|
| Cytokines | 1 | 1996 | 866 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1991 | 5 | 0.010 |
Why?
|
| Columbidae | 2 | 1977 | 12 | 0.000 |
Why?
|
| Sulfhydryl Reagents | 1 | 1984 | 6 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1983 | 13 | 0.000 |
Why?
|
| Biological Assay | 1 | 1981 | 88 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1977 | 31 | 0.000 |
Why?
|
| Amino Acids | 1 | 1976 | 131 | 0.000 |
Why?
|